Human Pyroglutamylated RFamide peptide receptor (QRFPR) ELISA Kit

Category: Assay Kits
Catalog
AE24858HU
(Ships in 5-10 business days)

Questions? Contact us

Call (800) 832-2611

arp-guarantee
- +
$0.00
More Information
Product Name Human Pyroglutamylated RFamide peptide receptor (QRFPR) ELISA Kit
Description GPR103 shares between 35% and 38% sequence identity in the transmembrane regions with various peptide receptors, including neuropeptide FF2, neuropeptide Y2, and galanin GalR1 receptors. Northern blot analysis of human brain regions revealed widespread expression, including transcripts of 4.0, 2.6 and 1.4 kb in the thalamus and hypothalamus, with a further 9.5-kb transcript in the hypothalamus and a 1.4-kb transcript in the pituitary.The deduced 431-amino acid protein contains the 7-transmembrane structure typical of G protein-coupled receptors. GPR103 shares 49% identity with NPFF1 (GPR147) and NPFF2 (GPR74). Quantitative PCR analysis detected highest GPR103 expression in brain, predominantly in retina, trigeminal ganglion, hypothalamus, and vestibular nucleus. This assay has high sensitivity and excellent specificity for detection of Human QRFPR. No significant cross-reactivity or interference between Human QRFPR and analogues was observed.
Synonyms AQ27, GPR103, MGC149217, SP9155, G protein-coupled receptor 103|OTTHUMP00000164030|QRFP receptor
Method Sandwich ELISA
Detection Range Request Information
Sensitivity Request Information
Reactivity Human
Sample Types Serum, Plasma, Other biological fluids.
Background GPR103 shares between 35% and 38% sequence identity in the transmembrane regions with various peptide receptors, including neuropeptide FF2, neuropeptide Y2, and galanin GalR1 receptors. Northern blot analysis of human brain regions revealed widespread expression, including transcripts of 4.0, 2.6 and 1.4 kb in the thalamus and hypothalamus, with a further 9.5-kb transcript in the hypothalamus and a 1.4-kb transcript in the pituitary.The deduced 431-amino acid protein contains the 7-transmembrane structure typical of G protein-coupled receptors. GPR103 shares 49% identity with NPFF1 (GPR147) and NPFF2 (GPR74). Quantitative PCR analysis detected highest GPR103 expression in brain, predominantly in retina, trigeminal ganglion, hypothalamus, and vestibular nucleus
Supplier Abebio

All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.